Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative
RNA-based therapeutics, will report second quarter 2014 financial
results before the NASDAQ Global Market opens on Thursday, August 7,
2014. Subsequently, at 8:00 a.m., Eastern Time, Chris Garabedian,
Sarepta’s president and chief executive officer, and Sandy Mahatme,
Sarepta’s chief financial officer, will host a conference call to
discuss second quarter financial results and to provide a corporate
update.
The conference call may be accessed by dialing 800-708-4539 for domestic
callers and 847-619-6396 for international callers. The passcode for the
call is 37748110. Please specify to the operator that you would like to
join the "Sarepta Second Quarter 2014 Earnings Call." The conference
call will be webcast live under the investor relations section of
Sarepta's website at www.sarepta.com
and will be archived there following the call for 90 days. Please
connect to Sarepta's website several minutes prior to the start of the
broadcast to ensure adequate time for any software download that may be
necessary.
About Sarepta Therapeutics
Sarepta Therapeutics is focused on developing first-in-class RNA-based
therapeutics to improve and save the lives of people affected by serious
and life-threatening rare and infectious diseases. The Company's diverse
pipeline includes its lead program eteplirsen, for Duchenne muscular
dystrophy, as well as potential treatments for some of the world's most
lethal infectious diseases. Sarepta aims to build a leading, independent
biotech company dedicated to translating its RNA-based science into
transformational therapeutics for patients who face significant unmet
medical needs. For more information, please visit us at www.sarepta.com.
Copyright Business Wire 2014